Truvian
Mingfu Chen, PhD, currently serves as Scientist 2 at Truvian, focusing on the development of a testing platform for FDA submission and executing product integration strategies. Prior experience includes roles as a Scientist at Truvian, where immunoassays and clinical chemistry assays were performed, and as a Graduate Research Assistant at Boston University, where the world's first microbe-derived nicotine electrochemical biosensor was invented, and significant funding was secured through grant proposals. Additional experience includes a CRISPR Diagnostics Internship at SiPhox Inc. and graduate research at the University at Buffalo, concentrating on gene delivery vectors and mentoring students. Mingfu Chen holds a PhD in Biomedical Engineering from Boston University, a Master's in Chemical and Biological Engineering from the University at Buffalo, and a Bachelor's in Polymer Science and Engineering from Nanjing Tech University.
This person is not in any teams
This person is not in any offices
Truvian
1 followers
We are disrupting the blood diagnostic industry by developing a lab-accurate, easy-to-use automated benchtop FDA-cleared and CLIA-waived blood testing system.